All In Biotech

Free tool

FAERS Monitor: Vandazole

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021806 or its brand name (Vandazole, Metronidazole). Reports on generic versions are filed under their own applications.

Reports

48,130

Serious

41,923

87% of reports

Hospitalization

19,848

Death reported

5,412

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,663
  • nausea3,461
  • off label use3,386
  • diarrhoea2,713
  • vomiting2,329
  • pyrexia2,288
  • headache2,259
  • pain2,123
  • abdominal pain2,122
  • fatigue1,960
  • dizziness1,686
  • condition aggravated1,637
  • dyspnoea1,598
  • acute kidney injury1,543
  • malaise1,470

Reports by year received

View as table
YearReports
2004459
2005480
2006483
2007512
2008320
2009677
2010859
20111,167
20121,431
20131,112
20141,452
20152,169
20162,477
20172,510
20184,185
20194,493
20203,820
20213,875
20223,401
20233,458
20243,163
20253,437
20262,187

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,029 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,5434.44.24,099
abdominal painSignal2,1224.03.84,808
pyrexiaSignal2,2882.92.82,879
condition aggravatedSignal1,6372.42.31,294
vomitingSignal2,3292.22.11,495
nausea3,4611.91.91,564
diarrhoea2,7131.81.81,068
off label use3,3861.71.6997
headache2,2591.61.5489
drug ineffective4,6631.51.5961
pain2,1231.51.5377
dizziness1,6861.51.4266
malaise1,4701.51.4221
dyspnoea1,5981.21.273
fatigue1,9601.11.118

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.